Delivery Order SPE2DB22D1106-SPE2DB23FEWW3

Award Date 8/25/23
Potential Completion Date 8/28/23
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $8,232 delivery order to Amerisourcebergen Drug Corporation for 4561708861 REMICADE 100 MG VIALS. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and calls for delivery to a location in Conshohocken, Pennsylvania by August 7, 2023 to support DLA programs. No subcontractors or set aside designations were identified. REMICADE is a biologic medication used to treat certain autoimmune disorders, indicating this...
The Defense Logistics Agency awarded a $11,774.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562052286 REMICADE 100 MG VIALS. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 5, 2023 through September 6, 2023. This delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of the Department of Defense's medical readiness programs. No...
The Defense Logistics Agency Troop Support Medical awarded a $12,826 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of Remicade. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order runs from June 29, 2023 through June 30, 2023. Remicade is a biologic medication used to treat certain autoimmune disorders. This delivery order was awarded under an indefinite-delivery/indefinite-quantity contract vehicle held by...
The Defense Logistics Agency awarded a $36,459 delivery order to Amerisourcebergen Drug Corporation for 4561806089 REMICADE 100 MG VIALS. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for delivery of the specified pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 15, 2023 to support DLA programs. No set aside designation or subcontractors were identified. REMICADE is an immunosuppressive drug used to treat...
The Defense Logistics Agency awarded a $14,718 delivery order to Amerisourcebergen Drug Corporation for 4561723599 REMICADE 100 MG VIALS. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide the pharmaceutical products to DLA from August 7-8, 2023 for use in agency medical supply programs. Amerisourcebergen will perform the order from its facility located in Conshohocken, Pennsylvania without involvement of major subcontractors. The...
<p>The Defense Logistics Agency awarded a $14,358 delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of the drug Remicade. The firm fixed price order is for performance at Amerisourcebergen's facility in Conshohocken, Pennsylvania from September 18-19, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this order supports DOD medical supply needs.</p>
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $6,250.50 firm fixed price delivery order contract to supply 4561696173 units of Remicade 100 mg vials. The single day contract has a period of performance from August 3 to August 4, 2023, with all work taking place in Conshohocken, Pennsylvania. As the Defense Logistics Agency is responsible for procuring pharmaceuticals and medical supplies for the U.S. Department of Defense, this delivery order was likely placed to...
The Defense Logistics Agency awarded a $9,808.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of the drug Remicade. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle and will be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania. Performance of the delivery order is required between June 21, 2023 and June 22, 2023. No subcontractors or set-aside designations were identified. The...
The Defense Logistics Agency Troop Support Medical awarded a $12,180 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 mg vials of Remicade. The place of performance is Conshohocken, Pennsylvania, with performance period spanning August 31, 2023 through September 1, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the rheumatoid arthritis treatment Remicade supports the Defense...
The U.S. Defense Logistics Agency (DLA) awarded a $34,436.74 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp for the supply of 4565677215 REMICADE 100 MG VIALS. This contract, which does not have a set-aside designation, has a period of performance through September 5, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB23FEWW3
    Delivery Order

The Defense Logistics Agency awarded a $14,162 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561948200 REMICADE 100 MG VIALS. REMICADE is a biologic medication used to treat certain autoimmune diseases. The place of performance for the delivery order is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is August 25-28, 2023. No major subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceutical supply vehicle and will provide needed REMICADE treatments to support the Agency's medical readiness programs.

Generated 12/23/23, 2:50 PM